BSX (BSX) Stock Analysis

BSX (BSX) is a publicly traded company in the HEALTHCARE sector. It trades at $47.69, carries a market capitalization of $71.32B, a price-to-earnings ratio of 20.08. This page summarizes the public market data, fundamentals, and frequently asked questions for BSX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $47.69
• Market Cap: $71.32B
• P/E Ratio: 20.08
• EPS: $2.39
• 52-Week High: $109.50
• 52-Week Low: $47.35

Market Sentiment

BSX currently has a Neutral sentiment score of -0.01.

About BSX

Boston Scientific Corporation (BSX) is a leading global medical device manufacturer that specializes in providing innovative solutions across key medical specialties, including cardiology, neuromodulation, and oncology. With a strong emphasis on research and development, the company is dedicated to enhancing patient outcomes through cutting-edge technology and strategic collaborations. Boston Scientific's extensive portfolio and commitment to advancing healthcare innovation position it to eff...

GNG Research Analysis

GNG Research scores BSX (BSX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BSX.

Frequently Asked Questions

Does BSX pay dividends?

BSX (BSX) does not currently pay a regular dividend.

What is BSX's P/E ratio?

BSX has a price-to-earnings (P/E) ratio of 20.08.

What is BSX's market cap?

BSX (BSX) has a market capitalization of $71.32B with a current stock price of $47.69.